123 related articles for article (PubMed ID: 29380463)
21. [Retrospective Analysis of Clinical Features and Prognosis of 84 Patients with Extranodal NK/T Cell Lymphoma in One Center].
Yang QS; Zhao SH; Jiang Y; Jiang TY; Yuan SZ; Su H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1390-1396. PubMed ID: 29070113
[TBL] [Abstract][Full Text] [Related]
22. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
23. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
24. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
25. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group.
Kim TM; Lee SY; Jeon YK; Ryoo BY; Cho GJ; Hong YS; Kim HJ; Kim SY; Kim CS; Kim S; Kim JS; Sohn SK; Song HH; Lee JL; Kang YK; Yim CY; Lee WS; Yuh YJ; Kim CW; Heo DS;
Ann Oncol; 2008 Aug; 19(8):1477-1484. PubMed ID: 18385201
[TBL] [Abstract][Full Text] [Related]
26. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
27. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of p53-related proteins and LMP-1 in nasal NK/T-cell lymphoma].
Xu G; Wang HF; He G; Xie K
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):351-5. PubMed ID: 19799083
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic and Immunophenotypic Features of Primary Intestinal Extranodal NK/T-Cell Lymphoma, Nasal Type.
Fang JC; Xia ZX; Wang CN; Li Z
Int J Surg Pathol; 2015 Dec; 23(8):609-16. PubMed ID: 26183848
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.
Braun FC; Grabarczyk P; Möbs M; Braun FK; Eberle J; Beyer M; Sterry W; Busse F; Schröder J; Delin M; Przybylski GK; Schmidt CA
Leukemia; 2011 Sep; 25(9):1494-501. PubMed ID: 21625233
[TBL] [Abstract][Full Text] [Related]
31. Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies.
Kim TM; Heo DS
Cancer Sci; 2009 Dec; 100(12):2242-8. PubMed ID: 19758393
[TBL] [Abstract][Full Text] [Related]
32. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
[TBL] [Abstract][Full Text] [Related]
33. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
[TBL] [Abstract][Full Text] [Related]
34. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.
Li YX; Liu QF; Fang H; Qi SN; Wang H; Wang WH; Song YW; Lu J; Jin J; Wang SL; Liu YP; Lu N; Liu XF; Yu ZH
Clin Cancer Res; 2009 Apr; 15(8):2905-12. PubMed ID: 19318493
[TBL] [Abstract][Full Text] [Related]
35. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
[TBL] [Abstract][Full Text] [Related]
36. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
[TBL] [Abstract][Full Text] [Related]
37. The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.
Liang L; Zhang Z; Wang Y; Nong L; Zheng Y; Qu L; Zhang B; Li T
Biomed Res Int; 2015; 2015():435423. PubMed ID: 26221594
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
39. Invasion-associated genes identified by gene expression profiling in extranodal natural killer/T-cell lymphoma, nasal type.
Yu JB; Zhang YC; Yang QP; Wang XL; Tang Y; Zhao S; Mo XM; Liu WP
Leuk Lymphoma; 2013 Jan; 54(1):90-8. PubMed ID: 22680768
[TBL] [Abstract][Full Text] [Related]
40. A20 and Cell Death-driven Inflammation.
Priem D; van Loo G; Bertrand MJM
Trends Immunol; 2020 May; 41(5):421-435. PubMed ID: 32241683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
